Philip Maes

609 total citations
22 papers, 105 citations indexed

About

Philip Maes is a scholar working on Hematology, Genetics and Infectious Diseases. According to data from OpenAlex, Philip Maes has authored 22 papers receiving a total of 105 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 7 papers in Genetics and 4 papers in Infectious Diseases. Recurrent topics in Philip Maes's work include Hemophilia Treatment and Research (6 papers), Hemoglobinopathies and Related Disorders (5 papers) and Blood groups and transfusion (4 papers). Philip Maes is often cited by papers focused on Hemophilia Treatment and Research (6 papers), Hemoglobinopathies and Related Disorders (5 papers) and Blood groups and transfusion (4 papers). Philip Maes collaborates with scholars based in Belgium, United States and Spain. Philip Maes's co-authors include Marek Wojciechowski, Marc Hainaut, Tine Boiy, Mira Meeus, Jack Lévy, Tessa Goetghebuer, Anthe Foubert, Sébastien Lobet, Berten Ceulemans and Dominique Trouet and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Philip Maes

20 papers receiving 104 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Maes Belgium 7 38 33 31 21 15 22 105
Mireille Mpoudi-Etame Cameroon 4 53 1.4× 61 1.8× 21 0.7× 8 0.4× 16 1.1× 6 105
Sabrinel Sahali France 4 35 0.9× 43 1.3× 31 1.0× 22 1.0× 10 0.7× 7 89
J Potgieter South Africa 7 123 3.2× 38 1.2× 68 2.2× 32 1.5× 6 0.4× 17 214
Massimo Coen Italy 5 23 0.6× 11 0.3× 21 0.7× 11 0.5× 2 0.1× 9 61
Mort J. Cowan United States 3 16 0.4× 5 0.2× 44 1.4× 34 1.6× 12 0.8× 4 111
Anneth Tumbo Tanzania 4 14 0.4× 11 0.3× 74 2.4× 12 0.6× 5 0.3× 5 142
Aalok R. Singh United States 4 11 0.3× 4 0.1× 21 0.7× 23 1.1× 4 0.3× 9 77
Patrícia Barrios Uruguay 6 14 0.4× 5 0.2× 48 1.5× 12 0.6× 26 1.7× 25 164
Jennifer Freed United States 5 17 0.4× 16 0.5× 22 0.7× 15 1.0× 8 96
Delphine Lemercier France 6 13 0.3× 14 0.4× 5 0.2× 4 0.2× 38 2.5× 10 69

Countries citing papers authored by Philip Maes

Since Specialization
Citations

This map shows the geographic impact of Philip Maes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Maes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Maes more than expected).

Fields of papers citing papers by Philip Maes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Maes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Maes. The network helps show where Philip Maes may publish in the future.

Co-authorship network of co-authors of Philip Maes

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Maes. A scholar is included among the top collaborators of Philip Maes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Maes. Philip Maes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foubert, Anthe, Mira Meeus, Philip Maes, et al.. (2023). Psychophysical assessment of pain in adults with moderate and severe haemophilia: A cross‐sectional study. Haemophilia. 29(5). 1243–1258. 3 indexed citations
2.
Foubert, Anthe, Nathalie Roussel, Philip Maes, et al.. (2023). The Classification of Suspected Predominant Nociplastic Pain in People with Moderate and Severe Haemophilia: A Secondary Exploratory Study. Biomedicines. 11(9). 2479–2479. 3 indexed citations
3.
Foubert, Anthe, Mira Meeus, Catherine Lambert, et al.. (2023). Joint status, pain and quality of life in elderly people with haemophilia: A case‐control study. Haemophilia. 29(6). 1621–1632. 4 indexed citations
4.
Maes, Philip, et al.. (2023). Erythrocytapheresis in Children and Young Adults with Hemoglobinopathies and Iron Overload in Need of Iron Chelation Therapy. Journal of Clinical Medicine. 12(19). 6287–6287. 1 indexed citations
5.
Hamlish, Tamara, Mary Pasquinelli, Michael T. Huber, et al.. (2022). A team-based approach to effective management of pain and opioid use disorder in patients with cancer: Case report. SHILAP Revista de lepidopterología. 8. 100196–100196.
6.
Lobet, Sébastien, Catherine Lambert, Anthe Foubert, et al.. (2022). ACTIVLIM‐Hemo: A new self‐reported, unidimensional and linear measure of activity limitations in persons with haemophilia. Haemophilia. 29(1). 317–328. 5 indexed citations
7.
Santoro, Cristina, Beng Fuh, Phu-Quoc Lê, et al.. (2022). Efficacy and safety in patients with haemophilia A switching to octocog alfa (BAY 81–8973): Final results of the global real‐world study, TAURUS. European Journal Of Haematology. 110(1). 77–87. 2 indexed citations
8.
Gulbis, Béatrice, Fleur Samantha Benghiat, Bénédicte Brichard, et al.. (2021). Factors Influencing Change in MCV and Age at Transplantation in the Belgian Sickle Cell Disease Registry. Blood. 138(Supplement 1). 4171–4171. 1 indexed citations
9.
Fleurimont, Judes, et al.. (2021). A Community Partnership to Improve Access to Buprenorphine in a Homeless Population. The Annals of Family Medicine. 19(1). 85–85. 10 indexed citations
10.
Schoonjans, An‐Sofie, Philip Maes, & Berten Ceulemans. (2021). Aggravation of valproic acid induced thrombocytopenia after the introduction of fenfluramine, a case report. Seizure. 93. 60–62. 3 indexed citations
11.
Santoro, Cristina, Beng Fuh, Phu-Quoc Lê, et al.. (2020). BAY 81‐8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study. European Journal Of Haematology. 105(2). 164–172. 4 indexed citations
12.
Vandamme, Sarah, et al.. (2020). Lupus anticoagulant hypoprothrombinaemia syndrome: An instructive paediatric case. Journal of Paediatrics and Child Health. 57(3). 443–444. 2 indexed citations
13.
Wojciechowski, Marek, et al.. (2019). Juvenile ecthyma gangrenosum caused by Pseudomonas aeruginosa revealing an underlying neutropenia: case report and review of the literature. Journal of the European Academy of Dermatology and Venereology. 33(4). 781–785. 7 indexed citations
14.
Maes, Philip, et al.. (2017). Renal papillary necrosis in patients with sickle cell disease: How to recognize this ‘forgotten’ diagnosis. Journal of Pediatric Urology. 13(3). 250–256. 12 indexed citations
15.
Maes, Philip, et al.. (2015). Orbital wall infarction in child with sickle cell disease. Acta Clinica Belgica. 70(6). 451–452. 7 indexed citations
16.
Maes, Philip, et al.. (2014). Extremely elevated cerebrospinal fluid protein levels in a child with neurologic symptoms: Beware of haemophagocytic lymphohistiocytosis. European Journal of Paediatric Neurology. 18(3). 427–429. 3 indexed citations
18.
Linden, Dimitri Van der, Marc Hainaut, Tessa Goetghebuer, et al.. (2008). Effectiveness of a early initiation of protease inhibitor-sparing antiretroviral regimen in human immunodeficiency virus-1 vertically infected infants. Retrovirology. 5(Suppl 1). P24–P24.
19.
Linden, Dimitri Van der, Marc Hainaut, Tessa Goetghebuer, et al.. (2007). EFFECTIVENESS OF EARLY INITIATION OF PROTEASE INHIBITOR-SPARING ANTIRETROVIRAL REGIMEN IN HUMAN IMMUNODEFICIENCY VIRUS-1 VERTICALLY INFECTED INFANTS. The Pediatric Infectious Disease Journal. 26(4). 359–361. 19 indexed citations
20.
Servais, Jean, Marc Hainaut, Philip Maes, et al.. (2002). Resistance testing in children changing human immunodeficiency virus type 1 protease inhibitor. The Pediatric Infectious Disease Journal. 21(3). 214–220. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026